Thrombocytopenia during pregnancy: From etiologic diagnosis to therapeutic management;Thrombopénie et grossesse : du diagnostic étiologique à la prise en charge thérapeutique

Presse Medicale

Volumn 37, Issue 9, 2008, Pages 1299-1307

  Federici, Laure ^a   Serraj, Khalid ^a   Maloisel, Frédéric ^a   Andrès, Emmanuel ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; DEXAMETHASONE; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LABETALOL; NICARDIPINE; RITUXIMAB; VINCRISTINE;

BLEEDING; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; HELLP SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY COMPLICATION; RISK FACTOR; SHORT SURVEY; TERATOGENICITY; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; THROMBOEMBOLISM;

DECISION TREES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RISK FACTORS; THROMBOCYTOPENIA;

EID: 50649113038     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.05.045     Document Type: Short Survey

References (61)

1. McCrae K.R. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis and management. Blood Rev 17 (2003) 7-14
2. Boehlen F., Hohlfeld P., Extermann P., Perneger T.V., and de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol 95 (2000) 29-33
3. Burrows R.F., and Kelton J.G. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 329 (1993) 1463-1466
4. Levy J.A., and Murphy L.D. Thrombocytopenia in pregnancy. J Am Board Fam Pract 15 (2002) 290-297
5. McCrae K.R., Samuels P., and Schreiber A.D. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 80 (1992) 2697-2714
6. 5. Shehata N., Burrows R., and Kelton J.G. Gestational thrombocytopenia. Clin Obstet Gynecol 42 (1999) 327-334
7. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med 346 (2002) 995-1008
8. Lescale K.B., Eddleman K.A., Cines D.B., Samuels P., Lesser M.L., McFarland J.G., et al. Antiplatelet antibody testing in thrombocytopenic pregnant women. Am J Obstet Gynecol 174 (1996) 1014-1018
9. Boehlen F., Hohlfeld P., Extermann P., and de Moerloose P. Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia. Obstet Gynecol 93 (1999) 169-173
10. Ajzenberg N., Dreyfus M., Kaplan C., Yvart J., Weill B., and Tchernia G. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood 92 (1998) 4573-4580
11. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785-799
12. Stella C.L., and Sibai B.M. Thrombophilia and adverse maternal-perinatal outcome. Clin Obstet Gynecol 49 (2006) 850-860
13. Mello G., Parretti E., Marozio L., Pizzi C., Lojacono A., Frusca T., et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 46 (2005) 1270-1274
14. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
15. Stepan H., Faber R., Dornhofer N., Huppertz B., Robitzki A., and Walther T. New insights into the biology of preeclampsia. Biol Reprod 74 (2006) 772-776
16. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005
17. Collinet P., Delemer-Lefebvre M., Dharancy S., Lucot J.P., Subtil D., and Puech F. The HELLP syndrome: diagnosis and therapeutic burden. Gynecol Obstet Fertil 34 (2006) 94-100
18. George J.N. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 10 (2003) 339-344
19. Furlan M., Robles R., and Lamie B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87 (1996) 4223-4234
20. Tsai H.M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87 (1996) 4235-4244
21. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 (1998) 1585-1594
22. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 (2001) 488-494
23. Lattuada A., Rossi E., Calzarossa C., Candolfi R., and Mannucci P.M. Mild to moderate reduction of a von Willebrand factor cleaving protease(ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica 88 (2003) 1029-1034
24. Kostousov V., Fehr J., and Bombeli T. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13. Thromb Res 118 (2006) 723-731
25. Zipfel P.F., and Skerka C. Complement dysfunction in hemolytic uremic syndrome. Curr Opin Rheumatol 18 (2006) 548-555
26. Caprioli J., Noris M., Brioschi S., Pianetti G., Castelletti F., Bettinaglio P., et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108 (2006) 1267-1279
27. Buyon J.P., Cronstein B.N., Morris M., Tanner M., and Weissmann G. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Am J Med 81 (1986) 194-200
28. Letsky E.A. Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15 (2001) 623-644
29. Taylor Jr. F.B., Toh C.H., Hoots W.K., Wada H., and Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001) 1327-1330
30. Hepner D.L., and Tsen L.C. Severe thrombocytopenia, type 2B von Willebrand disease and pregnancy. Anesthesiology 101 (2004) 1465-1467
31. Parnas M., Sheiner E., Shoham-Vardi I., Burstein E., Yermiahu T., Levi I., et al. Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128 (2006) 163-168
32. Webert K.E., Mittal R., Sigouin C., Heddle N.M., and Kelton J.G. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 102 (2003) 4306-4311
33. Silver R.M., Branch D.W., and Scott J.R. Maternal thrombocytopenia in pregnancy: time for a reassessment. Am J Obstet Gynecol 173 (1995) 479-482
34. George J.N., Woolf S.H., and Raskob G.E. Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med 30 (1998) 38-44
35. Samuels P., Bussel J.B., Braitman L.E., Tomaski A., Druzin M.L., Mennuti M.T., et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 323 (1990) 229-235
36. Le Thi Huong D., Wechsler B., Piette J.C., Bletry O., and Godeau P. Pregnancy and its outcome in systemic lupus erythematosus. QJM 87 (1994) 721-729
37. Pierangeli S.S., Chen P.P., and Gonzalez E.B. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol 13 (2006) 366-375
38. Clowse M.E., Magder L.S., Witter F., and Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 107 (2006) 293-299
39. Krause I., Blank M., Fraser A., Lorber M., Stojanovich L., Rovensky J., et al. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology 210 (2005) 749-754
40. Canadian Apheresis Study Group, Rock G.A., Shumak K.H., Buskard N.A., Blanchette V.S., Kelton J.G., Nair R.C., et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325 (1991) 393-397
41. Murrin R.J., and Murray J.A. Thrombotic thrombocytopenic purpura: aetiology, pathophysiology and treatment. Blood Rev 20 (2006) 51-60
42. Pereira A., Mazzara R., Monteagudo J., Sanz C., Puig L., Martinez A., et al. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange. Ann Hematol 70 (1995) 319-323
43. Coppo P., Wolf M., Veyradier A., Bussel A., Malot S., Millot G.A., et al. Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquiredthrombotic thrombocytopenic purpura. Br J Haematol 132 (2006) 66-74
44. Castella M., Pujol M., Julia A., Massague I., Bueno J., Ramon Grifols J., et al. Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases. Vox Sang 87 (2004) 287-290
45. Schiff D.E., Roberts W.D., Willert J., and Tsai H.M. Thrombocytopenia and severe hyperbilirubinemia in the neonatal period secondary to congenital thrombotic thrombocytopenic purpura and ADAMTS13 deficiency. J Pediatr Hematol Oncol 26 (2004) 535-538
46. Letsky E.A., and Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology. Br J Haematol 95 (1996) 21-26
47. Kelton J.G. Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev 16 (2002) 43-46
48. Khellaf M., Michel M., Schaeffer A., Bierling P., and Godeau B. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica 90 (2005) 829-832
49. Bierling P., and Godeau B. Intravenous immunoglobulin for autoimmune thrombocytopenic purpura. Hum Immunol 66 (2005) 387-394
50. Gross Z., Rodriguez J.J., and Stalnaker B.L. Vincristine for refractory autoimmune thrombocytopenic purpura in pregnancy. A case report. J Reprod Med 40 (1995) 739-742
51. Ojeda-Uribe M., Gilliot C., Jung G., Drenou B., and Brunot A. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 26 (2006) 252-255
52. Scully M., Starke R., Lee R., Mackie I., Machin S., and Cohen H. Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagul Fibrinolysis 17 (2006) 459-463
53. Kimby E., Sverrisdottir A., and Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 72 (2004) 292-295
54. Herold M., Schnohr S., and Bittrich H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol 19 (2001) 3439
55. Friedrichs B., Tiemann M., Salwender H., Verpoort K., Wenger M.K., and Schmitz N. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 91 (2006) 1426-1427
56. Cook R.L., Miller R.C., Katz V.L., and Cefalo R.C. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 78 (1991) 578-583
57. Maloisel F., Federici L., Zimmer J., Zamfir A., Affenberger S., and Andrès E. Purpura thrombopénique idiopathique et grossesse : expérience personnelle et revue de la littérature. Médecine Thérapeutique 348 (2006) 53
58. Gill K.K., and Kelton J.G. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 37 (2000) 275-289
59. Clowse M.E., Magder L., Witter F., and Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54 (2006) 3640-3647
60. Godeau B. Syndrome des anticorps anti-phospholipides. Hématologie 12 (2006) 101-110
61. George J.N. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354 (2006) 1927-1935